Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Genetic Polymorphism of CHRM2 in COPD: Clinical Significance and Therapeutic Implications.

Journal of cellular physiology - 1 Aug 2016

Cherubini Emanuela, Esposito Maria Cristina, Scozzi Davide, Terzo Fabrizio, Osman Giorgia Amira, Mariotta Salvatore, Mancini Rita, Bruno Pierdonato, Ricci Alberto

Abstract excerpt

Chronic Obstructive Pulmonary Disease (COPD) is a common preventable and treatable disease, characterized by persistent airflow limitation not fully reversible. However, a number of patients with COPD respond to bronchodilator agents. Some studies have shown polymorphisms in the b2-adrenergic (ADRb2) and muscarinic M2 and M3 receptors (CHRM) that may participate in the modulation of the receptor responses. This...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Bronchodilator Agents
Share to Muscarinic Antagonists

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Pulmonary Disease, Chronic Obstructive

Share to Receptor, Muscarinic M2

Share to Receptor, Muscarinic M3

Share to Receptors, Adrenergic, beta-2

Share to Receptors, Muscarinic

Share to Respiratory Function Tests

Source

Identifiers

PMID: 26633752
DOI: 10.1002/jcp.25277

Genes

CHRM2
CHRM3

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Genetic Polymorphism of CHRM2 in COPD: Clinical Significance and Therapeutic Implications.PMID 26633752Read ↗

Variants of the ADRB2 Gene in COPD: Systematic Review and Meta-Analyses of Disease Risk and Treatment Response.Semantic proximity Read ↗

Effect of polymorphisms in the β2-adrenergic receptor on the susceptibility and pulmonary function of patients with chronic obstructive pulmonary disease: a meta analysis.Semantic proximity Read ↗

[Association of A/T polymorphism of the CHRM2 gene with bronchodilator response to ipratropium bromide in asthmatic children].Semantic proximity Read ↗

The impact of genomic variants on patient response to inhaled bronchodilators: a comprehensive update.Semantic proximity Read ↗

Beta2-adrenergic receptor gene haplotypes and bronchodilator response in Egyptian patients with chronic obstructive pulmonary disease.Semantic proximity Read ↗

Pharmacogenetics of chronic obstructive pulmonary disease.Semantic proximity Read ↗

Effect of ADRB2 polymorphisms on the efficacy of salmeterol and tiotropium in preventing COPD exacerbations: a prespecified substudy of the POET-COPD trial.Semantic proximity Read ↗

Nicotinic acetylcholine receptor variants associated with susceptibility to chronic obstructive pulmonary disease: a meta-analysis.Semantic proximity Read ↗

Pharmacogenetics of chronic obstructive pulmonary disease: challenges and opportunities.Semantic proximity Read ↗

Association Between ADRB2 Genetic Polymorphisms and the Risk of Chronic Obstructive Pulmonary Disease: A Case-Control Study in a Chinese Population.Semantic proximity Read ↗

Association of beta2-adrenoreceptor genotypes with bronchodilatory effect of tiotropium in COPD.Semantic proximity Read ↗

Genetic variations in scavenger and β₂-adrenergic receptors and risk of pulmonary disease.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.